期刊文献+

小剂量肝素联合尿激酶治疗儿童原发性肾病综合征伴严重高凝状态 被引量:3

原文传递
导出
摘要 多数原发性肾病综合征(PNS)患儿都存在不同程度的高凝状态,应用肝素或尿激酶对PNS合并高凝状态进行治疗已为业界所公认,但临床上发现,有些患儿单用肝素或单用尿激酶疗效欠佳,由此,我们想到联合应用小剂量肝素和尿激酶治疗。本研究对21例确诊为PNS并伴有严重高凝状态的儿童在应用激素治疗的基础上,给予小剂量肝素联合尿激酶治疗,疗效较好,现报告如下。
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2011年第11期921-922,共2页 Chinese Journal of Contemporary Pediatrics
基金 江苏省卫生厅课题资助(H200613)
  • 相关文献

参考文献4

二级参考文献44

  • 1孙嫱,沈颖.Meta分析评价环磷酰胺对儿童肾病综合征的治疗作用[J].中华儿科杂志,2006,44(3):199-201. 被引量:21
  • 2莫樱,陈述枚.肾病综合征频复发及激素依赖的治疗[J].中国实用儿科杂志,2007,22(6):412-416. 被引量:12
  • 3Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis ,2003,42 : 1107-1113.
  • 4Eddy AA,Symons JM. Nephrotic syndrome in childhood. Lancet, 2003.362:629-639.
  • 5Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Pedia Child Health,2007,43:337-341.
  • 6易著文.小儿临床肾脏病学//易著文,钟巧.肾病综合征.北京:人民卫生出版社,1998:346-361.
  • 7Koskinies O, Vilska J, Rapola J, et al. Long-term outcome of primary nephrotic syndrome. Arch Dis Child, 1987,57:544-548.
  • 8Tarshish P, Tobin JN, Bwenstein J,et al. Prognostic significance of the early course of minimal change nephrotic syndrome:report of the International Study of Kidney Disease in Children. J Am Soc Nephrol, 1997,8:769-779.
  • 9American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Eur Heart J ,2003,24 : 1965-1991.
  • 10Schrier RW. Disease of the kidney and urinary tract. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2007: 1585- 1672.

共引文献1835

同被引文献31

  • 1李健斋,王抒,曾平.非高密度脂蛋白胆固醇用于评估及预测冠心病危险[J].中华心血管病杂志,2004,32(11):963-966. 被引量:45
  • 2陈丹,陈燕,曾彩虹,刘志红,黎磊石.肾小球疾病患者肾间质泡沫细胞的分布及其临床意义[J].肾脏病与透析肾移植杂志,2006,15(4):322-328. 被引量:5
  • 3杜烨辉,李德天.肝素对大鼠肾小球系膜细胞增殖和核因子κB的抑制作用[J].中国药物与临床,2007,7(4):289-291. 被引量:3
  • 4姚勇,徐国宾,张英,杨霁云,朱丽华.实验性高脂血症对阿霉素肾病鼠的加速肾毒作用[J].北京医科大学学报,1997,29(2):139-141. 被引量:4
  • 5de Saint-Martin A,Terzic J,Christmann D,et al.Superior sagittal sinus thrombosis and neplarotic syndrome:favorable outcome with low molecular weight heparin[J]. Arch Pediatr, 1997;4(9): 849-852.
  • 6Sagriqanti A,Barsotti G.Hypercoagulability intraglomerular coagulation and thromboembolism in nephrotic syndrome[J].Nephron, 1995;70(3):271.
  • 7Taine C Fartoukh M,Houel R,et al.Spontaneous hemonedastinum complicating st eroid-induced.Mediasfinal lipomatosis[J] .Chest,2001; 120( 1 ):311.
  • 8Wang YC, Chuang FR, Lee WC, et al.Low-Molecular-Weight HeparinSuccessfully Used to Treat a Nephrotic Patient Complicated by Superior Mesenterie Vein Thrombosis and Portal Vein Thrombosis[J].Med Prine Pratt,2011 ;20(2): 196,- 199.
  • 9Mahmud S,Jahan S,Hossain MM.Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relaps[J].Mymensingh Mod J,2011 ;20(3):402-406.
  • 10Gyebi L, Soltani Z, Reisin E. Lipid nephrotoxicity: new concept for an old disease[J]. Curr Hypertens Rep, 2012, 14(2): 177-181.

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部